-
-
Psychiatrist Challenges Ethics of Yale Drug Experiment
The ethics of this radical drug experiment is being challenged by Dr. Jerald Block, a forthright psychiatrist and experienced system's analyst. His critical appraisal, published in the Bioethics Forum, Hastings Center Report.
-
AHRP Comments on Smallpox Vaccine Testing on Children
THE ALIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Avenue, Suite 28P New York, NY 10023 www.ahrp.org FDA Docket Number 02N-0466 Comments re: Proposed smallpox vaccine trial to test the safety of Dryvax administration to children 2 to 5 years of age Recent public and professional debate about smallpox…
-
Research Compliance Note. Thomas Dalglish, JD, PhD
Analysis of 94 OHRP Letters of Determination, July 1, 2000 to January 31, 2001 Research Compliance Note. Thomas Dalglish, JD, PhD * The views expressed in the ‘Research Compliance Note’ below are the personal opinions of the author, do not reflect any official position of the University of Washington, and…
-
Fed Investigation Report: AIDS Drug Tests on Foster Kids Violated Rules
Fed Investigation Report: AIDS Drug Tests on Foster Kids Violated Rules Thu, 16 Jun 2005 related link: OHRP Letter of Determination, Columbia University Medical Center, May 23, 2005 (32 K pdf) The Associated Press reports that an investigation by the U.S. Department of Health and Human Services’ Office of Human…
-
Director of OHRP Dr. Greg Koski resigns
Director of OHRP Dr. Greg Koski resigns Date: Wed, 16 Oct 2002 Dr. Greg Koski has tendered his resignation as director of the federal Office of Human Research Protections. We agree, in principle, with Dr. Koski’s assessment: “to preserve public trust in research, the scientific community must go beyond a…
-
Informed Consent | Informed Consent Waivers | Investigations | Medical Research Ethics | Unethical Experiments
OHRP Letter to ARDSNetwork re: Investigation of Acute Respiratory DistressSyndrome
OHRP Investigation of experimental treatment for Acute Respiratory Distress Syndrome. ARDSNet studies: ARMA, FACCT, and ALVEOLI Table of Contents to Fax from OHRP page 1 Oct. 7, 2002 OHRP letter to: Ronald S. Newvbower, Ph.D(Mass. General Hospital), Lee E. Limbird, Ph.D. (Vanderbilt University), and Robert Kay, MD) (Cleveland Clinic Foundation)…
-
Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials
Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials Sun, 19 Jun 2005 The dirty secret is finally tumbling out: Government agencies that are supposed to protect the public interest are shielding drug manufacturers by helping to conceal deaths and suicides in drug experiments….
-
Research Protection: SCIENCE / Fed Paper
Research Protection: SCIENCE / Fed Paper Mon, 28 Oct 2002 SCIENCE magazine (below) reported about “the bumpy road” of Dr. Greg Koski’s tenure as director of the federal Office of Human Research Protections (OHRP), and how his resignation is being perceived by some. An article in The FEDERAL PAPER focused…
-
August 20b, 2001
AHRP Alliance for Human Research Protection AHRP Speaks Out Return to Home Page AHRP Speaks Out Press Releases August 20b, 2001 The Scientist News reports on AHRP as New Advocacy Group to Police Human Research A group of patient and social justice advocates plan to form an Alliance for Human…
-
AHRP Files Court Brief to Protect Children from Harmful Research
October 1, 2001 Text of AHRP Amicus Brief filed with the Maryland Court of Appeals in support of the Court’s ruling against Kennedy Krieger Institute for exposing children to lead poison in an experiment. The Court of Appeals Decision Validates AHRP’s Stand Against Using Children in Harmful Research Experiments. ___________________________________________________…
-
OHRP Compliance Letters
ETHICAL AND POLICY ISSUES IN RESEARCH INVOLVING HUMAN PARTICIPANTS National Bioethics Advisory Commitee (NBAC) Final Report, 2001 Exhibit 3.1: Office of Protection from Research Risks (OPRR) Compliance Oversight Investigations Resulting in Restrictions/Actions to Institutions that have Multiple Project Assurances (MPA) between January 1990 – June 2000 Year, Institution and Action…